MedTrace Logo

Bright Light Therapy for Individuals With Dementia

NCT02800850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2016-06-17

No results posted yet for this study

Summary

Many older adults with dementia living in long-term care facilities experience depression and agitation, which cause angst and personal suffering. Prior to this research, evidence was inconclusive but indicated that bright light exposure may reduce depression and agitation in long-term care residents with dementia. The purpose of this study was to determine if the degree of improvement in depression and agitation scores over the course of eight weeks was significantly greater in persons with dementia receiving bright light exposure than in persons with dementia receiving placebo light exposure. Sixty individuals participated in the study, with 30 in the bright light group and 30 in the low level light group.

Conditions

Interventions

BEHAVIORAL

Bright Light

BEHAVIORAL

Placebo Light

Sponsors & Collaborators

  • Commonwealth Care of Roanoke, Inc.

    collaborator UNKNOWN

  • Virginia Center on Aging (ARDRAF)

    collaborator UNKNOWN

  • Radford University

    lead OTHER

Principal Investigators

  • Lisa L Onega, PhD, RN, MBA · Radford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-07-31
Completion
2014-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02800850 on ClinicalTrials.gov